In today’s briefing:
- Guodian Tech (1296 HK): Done Deal As Pre-Cons Fulfilled
- Chindata the Next Chinese ADR Privatisation Target?
- AKM Industrial’s Offer Risk/Reward – Pre-Condition Satisfied
- Tencent 1Q2021 Earnings Preview: Earnings Weakness to Continue
- InnoCare Pharma Ltd (9969.HK) – Lack of Clear Commercialization Prospects
- Uju Holding IPO Lock-Up – Would Improve the Liquidity but We Wouldn’t Be Buyers
- Morning Views Asia: KWG Living Group
- Zhuangyuan Pasture (1533 HK): H-Share Offer Via Buyback
Guodian Tech (1296 HK): Done Deal As Pre-Cons Fulfilled
- Guodian Technology & Environment Group (1296 HK)‘s (GTE) pre-cons are now fulfilled – bang in line with my timetable estimate.
- The Composite Document should be despatched to the shareholders on or before 29 April 2022.
- Assuming all goes to plan – and there is every indication it will – payment under the Offer is expected around mid-June.
Chindata the Next Chinese ADR Privatisation Target?
- A Bloomberg article claimed that Chindata Group (CD US) is attracting takeover interest from GDS Holdings (ADR) (GDS US), PAG and EdgeConneX. Shares rose 9.8% to close at $4.81.
- Potential privatisation will require the blessing of Bain Capital, the largest shareholder. Chindata’s track record of beating guidance, modest leverage and the beaten-down rating make it a target.
- A forward EV/EBITDA multiple of 8.9x, in line with 21Vianet Group (VNET US)’s proposed acquisition multiple, would imply $6.85 per ADS.
AKM Industrial’s Offer Risk/Reward – Pre-Condition Satisfied
- AKM Industrial (1639 HK)’s privatisation offer from Alpha Luck and AKM Meadville of HK$1.8345 consists of a base offer (HK$1.82) and a final dividend (HK1.45 cent).
- The pre-condition was fulfilled on 22 April. The latest date for the despatch of the scheme document has been extended to 10 June.
- Shareholders with blocking stakes have previously provided irrevocables. At last close and for an early-August effective date, the gross and annualised spread to the offer is 3.1% and 10.7%, respectively.
Tencent 1Q2021 Earnings Preview: Earnings Weakness to Continue
- Tencent (700 HK) will announce its first quarter 2021 results on 18th May 2022.
- Since 3Q2021, Tencent’s earnings have started to decelerate, and the previous quarter marked the slowest ever revenue growth for the company since 2004.
- We expect Tencent’s earnings weakness to continue well into 1H2022E due to slowdown in online games and online advertising businesses.
InnoCare Pharma Ltd (9969.HK) – Lack of Clear Commercialization Prospects
- InnoCare was approved to list in the SSE STAR Market, and the Company also released its improving financial performance in 2021. However, the outlook for InnoCare remains challenging and uncertain.
- Either orelabrutinib or the pipeline, they don’t have pricing power due to lack of sufficient competitiveness and slower development progress, which means that their commercialization performance is highly uncertain.
- There’s no definite commercialization outlook for InnoCare, with a far distance from becoming a biopharma. InnoCare was overvalued and could be attractive if the market value could be 50% off.
Uju Holding IPO Lock-Up – Would Improve the Liquidity but We Wouldn’t Be Buyers
- Uju Holding raised US$103m from its Hong Kong IPO in Nov 2021, where the IPO had been priced at the bottom end.
- The offering was only mildly oversubscribed and the two cornerstones in the deal, Bytedance and Green Better (Xiaomi), had combined to subscribe to 12.6% of the offer shares
- The cornerstones and Pre-IPO investors’ stake are coming up for lockup expiry. The latter will see half of their stakes unlocked, with the remainder locked up for another six months.
Morning Views Asia: KWG Living Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
Zhuangyuan Pasture (1533 HK): H-Share Offer Via Buyback
- PRC dairy farmer Lanzhou Zhuangyuan Pasture (1533 HK) has announced a Conditional Cash Offer for all H-shares at $10.89/share.
- The Offer is being done via a Voluntary Cash Offer, therefore an onerous 90% tendering condition is present.
- This transaction could potentially be wrapped up late-July. The FY21 dividend may also be added to terms.
Before it’s here, it’s on Smartkarma